- Austria (Website)
- Czech Republic (Website)
- Denmark (Website)
- Finland (Website)
- France (Website)
- Germany (Website)
- Italy (Website)
- Ivory Coast
bioMérieux reinforces its offering of High Medical Value immunoassay biomarkers with the acquisition of Astute Medical
bioMérieux, a world leader in the field of in vitro diagnostics, announces today the acquisition of Astute Medical Inc., a company dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers.
Lord Jim O’Neill joins bioMérieux in a knowledge exchange on the challenge of antimicrobial resistance
Marcy l'Etoile, France, March 7, 2017 - bioMérieux, a world leader in infectious disease diagnostics, committed to the fight against antimicrobial resistance (AMR), organized today a panel discussion with Lord Jim O’Neill, an influential economist, politician and philanthropist who chaired the Review on Antimicrobial Resistance.
February 28, 2016 – The Board of Directors of bioMérieux, a world leader in the field of in vitro diagnostics, met on February 27 under the chairmanship of Alexandre Mérieux and approved the audited consolidated financial statements for the year ended December 31, 2017.
Marcy l'Étoile, January 23, 2018 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the twelve months ended December 31, 2017.
The Board of Directors of bioMérieux approved the appointment of Alexandre Mérieux as Chairman and CEO of the Company, taking effect immediately.
Please be advised that bioMérieux Inc. sites in Durham, St. Louis, Louisville and Lombard will be closed as indicated below in observance of the upcoming holidays. We encourage you to place your orders with these dates in mind to ensure you receive products as needed: